메뉴 건너뛰기




Volumn 122, Issue 2, 2012, Pages 60-68

A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis

Author keywords

low dose; migraine; prophylaxis; sodium valproate; topiramate

Indexed keywords

ERGOTAMINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TOPIRAMATE; VALPROIC ACID;

EID: 84855780797     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.626908     Document Type: Article
Times cited : (37)

References (29)
  • 1
    • 33749252906 scopus 로고    scopus 로고
    • Migraine in children and adolescents: A guide to drug treatment
    • DOI 10.2165/00023210-200620100-00003
    • Hamalainen ML.Migraine in children and adolescents: a guide to drug treatment. CNS Drugs. 2006;20:813-20. (Pubitemid 44484245)
    • (2006) CNS Drugs , vol.20 , Issue.10 , pp. 813-820
    • Hamalainen, M.L.1
  • 2
    • 33846576913 scopus 로고    scopus 로고
    • Migraine prevalence, disease burden, and the need for preventive therapy
    • DOI 10.1212/01.wnl.0000252808.97649.21, PII 0000611420070130000008
    • Lipton RB, Bigal ME, Diamond M, Freitag F, ReedML, Stewart WF; Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-9. (Pubitemid 46184209)
    • (2007) Neurology , vol.68 , Issue.5 , pp. 343-349
    • Lipton, R.B.1    Bigal, M.E.2    Diamond, M.3    Freitag, F.4    Reed, M.L.5    Stewart, W.F.6
  • 3
    • 33646231746 scopus 로고    scopus 로고
    • Prophylactic pharmacotherapy for migraine headaches
    • Buchanan TM, Ramadan NM. Prophylactic pharmacotherapy for migraine headaches. Semin Neurol. 2006;26:188-98.
    • (2006) Semin Neurol. , vol.26 , pp. 188-198
    • Buchanan, T.M.1    Ramadan, N.M.2
  • 4
    • 26444585529 scopus 로고    scopus 로고
    • Migränetherapie
    • DOI 10.1007/s00108-005-1459-9
    • Diener HC, Limmroth V. Migraine therapy. Internist (Berl). 2005;46:1087-95. (Pubitemid 41424867)
    • (2005) Internist , vol.46 , Issue.10 , pp. 1087-1095
    • Diener, H.-C.1    Limmroth, V.2
  • 6
    • 0030900921 scopus 로고    scopus 로고
    • Divalproex sodium in migraine prophylaxis: A dose-controlled study
    • DOI 10.1046/j.1468-2982.1997.1702103.x
    • Klapper J. Divalprex sodium in migraine prophylaxis: a dosecontrolled study. Cephalalgia 1997;17:103-08. (Pubitemid 27166264)
    • (1997) Cephalalgia , vol.17 , Issue.2 , pp. 103-108
    • Klapper, J.1
  • 10
    • 2342461018 scopus 로고    scopus 로고
    • Topiramate in migraine prevention: Results of a large controlled trial
    • DOI 10.1001/archneur.61.4.490
    • Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61:490-5. (Pubitemid 38923736)
    • (2004) Archives of Neurology , vol.61 , Issue.4 , pp. 490-495
    • Silberstein, S.D.1    Neto, W.2    Schmitt, J.3    Jacobs, D.4
  • 11
    • 17244372257 scopus 로고    scopus 로고
    • Molecular pharmacology of topiramate: Managing seizures and preventing migraine
    • DOI 10.1111/j.1526-4610.2005.4501006.x
    • White HS. Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache 2005;45:s48-56. (Pubitemid 40530183)
    • (2005) Headache , vol.45 , Issue.SUPPL. 1
    • White, H.S.1
  • 12
    • 33846998336 scopus 로고    scopus 로고
    • Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized double blind placebo-controlled trial
    • Silberstein SD, Lipton RB, Dodick DW. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double blind, placebo-controlled trial. Headache 2007;47:170-80.
    • (2007) Headache , vol.47 , pp. 170-180
    • Silberstein, S.D.1    Lipton, R.B.2    Dodick, D.W.3
  • 13
    • 0038799905 scopus 로고    scopus 로고
    • Topiramate in the preventive treatment of episodic migraine: A combined analysis from pilot, double-blind, placebo-controlled trials
    • Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr. 2003;8(6):428-32. (Pubitemid 36765009)
    • (2003) CNS Spectrums , vol.8 , Issue.6 , pp. 428-432
    • Edwards, K.R.1    Potter, D.L.2    Wu, S.-C.3    Kamin, M.4    Hulihan, J.5
  • 15
    • 17244362814 scopus 로고    scopus 로고
    • Practical use of topiramate for migraine prevention
    • DOI 10.1111/j.1526-4610.2005.4501007.x
    • Brandes JL. Practical use of topiramate for migraine prevention. Headache 2005;45(Suppl. 1):S66-73. (Pubitemid 40530185)
    • (2005) Headache , vol.45 , Issue.SUPPL. 1
    • Brandes, J.L.1
  • 16
    • 0035070561 scopus 로고    scopus 로고
    • Kognitive beeinträchtigungen unter add-on-therapie mit topiramat
    • DOI 10.1007/s001150050750
    • Huppertz HJ, Quiske A, Schulze-Bonhage A. Cognitive impairments due to add-on therapy with topiramate. Nervenarzt 2001;72:275-80. (Pubitemid 32288970)
    • (2001) Nervenarzt , vol.72 , Issue.4 , pp. 275-280
    • Huppertz, H.J.1    Quiske, A.2    Schulze-Bonhage, A.3
  • 17
    • 53549101657 scopus 로고    scopus 로고
    • A double-blind randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
    • Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand. 2008;118(5):301-5.
    • (2008) Acta Neurol. Scand. , vol.118 , Issue.5 , pp. 301-305
    • Ashtari, F.1    Shaygannejad, V.2    Akbari, M.3
  • 18
    • 33645459537 scopus 로고    scopus 로고
    • Comparison of the effect of topiramate and sodium valproate in migraine prevention: A randomized blinded crossover study
    • Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache 2006;46(4):642-8.
    • (2006) Headache , vol.46 , Issue.4 , pp. 642-648
    • Shaygannejad, V.1    Janghorbani, M.2    Ghorbani, A.3    Ashtary, F.4    Zakizade, N.5    Nasr, V.6
  • 20
    • 84855783480 scopus 로고    scopus 로고
    • Time trend in outpatient warfarin therapy based on international normalization ratio
    • Mohebbi A, Honarvar M, Behzadi A. Time trend in outpatient warfarin therapy based on international normalization ratio. Iranian Heart J. 2008;9(3):37-41.
    • (2008) Iranian Heart J. , vol.9 , Issue.3 , pp. 37-41
    • Mohebbi, A.1    Honarvar, M.2    Behzadi, A.3
  • 21
    • 84873063785 scopus 로고    scopus 로고
    • The International Classification of Headache Disorders 2nd ed Cephalagia Oxford England UK: Blackwell Publishing
    • The International Classification of Headache Disorders. 2nd ed. Headache Classification Subcommittee of the International Headache Society. Cephalagia (Oxford, England, UK: Blackwell Publishing) 24(1): 1-160.
    • Headache Classification Subcommittee of the International Headache Society , vol.24 , Issue.1 , pp. 1-160
  • 22
    • 0035651241 scopus 로고    scopus 로고
    • Topiramate in migraine prevention: A double-blind, placebo-controlled study
    • DOI 10.1046/j.1526-4610.2001.01190.x
    • Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001;41(10):968-75. (Pubitemid 34008132)
    • (2001) Headache , vol.41 , Issue.10 , pp. 968-975
    • Storey, J.R.1    Calder, C.S.2    Hart, D.E.3    Potter, D.L.4
  • 24
    • 77955706282 scopus 로고    scopus 로고
    • Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: A randomized double blind study
    • Bavrasad R, Nejad SEM, Yarahmadi AR, Sajedi SI, Rahimi F. Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: a randomized double blind study. Science Alert. 2010;670-5
    • (2010) Science Alert. , pp. 670-675
    • Bavrasad, R.1    Nejad, S.E.M.2    Yarahmadi, A.R.3    Sajedi, S.I.4    Rahimi, F.5
  • 25
    • 33750886818 scopus 로고    scopus 로고
    • Topiramate for migraine prevention in adolescents: A pooled analysis of efficacy and safety
    • DOI 10.1111/j.1526-4610.2006.00610.x
    • Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS; Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache 2006;46(10):1503-10. (Pubitemid 44722188)
    • (2006) Headache , vol.46 , Issue.10 , pp. 1503-1510
    • Winner, P.1    Gendolla, A.2    Stayer, C.3    Wang, S.4    Yuen, E.5    Battisti, W.P.6    Nye, J.S.7
  • 27
    • 77953471199 scopus 로고    scopus 로고
    • A pilot study of topiramate dosage for migraine prophylaxis in an Asian population
    • Lo YL, Lum SY, Fook-Chang S, Siow HC. A pilot study of topiramate dosage for migraine prophylaxis in an Asian population. Headache Pain. 2010;11:175-8.
    • (2010) Headache Pain. , vol.11 , pp. 175-178
    • Lo, Y.L.1    Lum, S.Y.2    Fook-Chang, S.3    Siow, H.C.4
  • 28
    • 33947219853 scopus 로고    scopus 로고
    • Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study)
    • DOI 10.1111/j.1526-4610.2006.00599.x
    • Gupta P, Singh S, Goyal V, Shukla G, Behari M. Lowdose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache 2007;47(3):402-12. (Pubitemid 46426409)
    • (2007) Headache , vol.47 , Issue.3 , pp. 402-412
    • Gupta, P.1    Singh, S.2    Goyal, V.3    Shukla, G.4    Behari, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.